Advancing pathogen genomics in resource-limited settings
© 2023 The Author(s)..
Genomic sequencing has emerged as a powerful tool to enhance early pathogen detection and characterization with implications for public health and clinical decision making. Although widely available in developed countries, the application of pathogen genomics among low-resource, high-disease burden settings remains at an early stage. In these contexts, tailored approaches for integrating pathogen genomics within infectious disease control programs will be essential to optimize cost efficiency and public health impact. We propose a framework for embedding pathogen genomics within national surveillance plans across a spectrum of surveillance and laboratory capacities. We adopt a public health approach to genomics and examine its application to high-priority diseases relevant in resource-limited settings. For each grouping, we assess the value proposition for genomics to inform public health and clinical decision-making, alongside its contribution toward research and development of novel diagnostics, therapeutics, and vaccines.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
|---|---|
| Enthalten in: |
Cell genomics - 3(2023), 12 vom: 13. Dez., Seite 100443 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pronyk, Paul Michael [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Emerging infectious diseases |
|---|
| Anmerkungen: |
Date Completed 21.12.2023 Date Revised 21.12.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.xgen.2023.100443 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366067885 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366067885 | ||
| 003 | DE-627 | ||
| 005 | 20231227135538.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.xgen.2023.100443 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1234.xml |
| 035 | |a (DE-627)NLM366067885 | ||
| 035 | |a (NLM)38116115 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pronyk, Paul Michael |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advancing pathogen genomics in resource-limited settings |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.12.2023 | ||
| 500 | |a Date Revised 21.12.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 The Author(s). | ||
| 520 | |a Genomic sequencing has emerged as a powerful tool to enhance early pathogen detection and characterization with implications for public health and clinical decision making. Although widely available in developed countries, the application of pathogen genomics among low-resource, high-disease burden settings remains at an early stage. In these contexts, tailored approaches for integrating pathogen genomics within infectious disease control programs will be essential to optimize cost efficiency and public health impact. We propose a framework for embedding pathogen genomics within national surveillance plans across a spectrum of surveillance and laboratory capacities. We adopt a public health approach to genomics and examine its application to high-priority diseases relevant in resource-limited settings. For each grouping, we assess the value proposition for genomics to inform public health and clinical decision-making, alongside its contribution toward research and development of novel diagnostics, therapeutics, and vaccines | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a emerging infectious diseases | |
| 650 | 4 | |a genomics | |
| 650 | 4 | |a pathogen genomics | |
| 650 | 4 | |a resource-limited settings | |
| 650 | 4 | |a surveillance | |
| 650 | 4 | |a whole-genome sequencing | |
| 700 | 1 | |a de Alwis, Ruklanthi |e verfasserin |4 aut | |
| 700 | 1 | |a Rockett, Rebecca |e verfasserin |4 aut | |
| 700 | 1 | |a Basile, Kerri |e verfasserin |4 aut | |
| 700 | 1 | |a Boucher, Yann Felix |e verfasserin |4 aut | |
| 700 | 1 | |a Pang, Vincent |e verfasserin |4 aut | |
| 700 | 1 | |a Sessions, October |e verfasserin |4 aut | |
| 700 | 1 | |a Getchell, Marya |e verfasserin |4 aut | |
| 700 | 1 | |a Golubchik, Tanya |e verfasserin |4 aut | |
| 700 | 1 | |a Lam, Connie |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Raymond |e verfasserin |4 aut | |
| 700 | 1 | |a Mak, Tze-Minn |e verfasserin |4 aut | |
| 700 | 1 | |a Marais, Ben |e verfasserin |4 aut | |
| 700 | 1 | |a Twee-Hee Ong, Rick |e verfasserin |4 aut | |
| 700 | 1 | |a Clapham, Hannah Eleanor |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Linfa |e verfasserin |4 aut | |
| 700 | 1 | |a Cahyorini, Yorin |e verfasserin |4 aut | |
| 700 | 1 | |a Polotan, Francisco Gerardo M |e verfasserin |4 aut | |
| 700 | 1 | |a Rukminiati, Yuni |e verfasserin |4 aut | |
| 700 | 1 | |a Sim, Eby |e verfasserin |4 aut | |
| 700 | 1 | |a Suster, Carl |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Gavin J D |e verfasserin |4 aut | |
| 700 | 1 | |a Sintchenko, Vitali |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell genomics |d 2021 |g 3(2023), 12 vom: 13. Dez., Seite 100443 |w (DE-627)NLM333578430 |x 2666-979X |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2023 |g number:12 |g day:13 |g month:12 |g pages:100443 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.xgen.2023.100443 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2023 |e 12 |b 13 |c 12 |h 100443 | ||